Suchergebnisse - (Person:"Pierson, Sheila K")

PubPharm (11)

1

Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes

enthalten in: Blood advances | 2023

von Pierson, S. | Lim, M. | Srkalovic, G. | +13

2

The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry

enthalten in: British journal of haematology | 2022

von Fajgenbaum, D. | Pierson, S. | Kanhai, K. | +8

3

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2021

von Pierson, S. | Shenoy, S. | Oromendia, A. | +22

4

ACCELERATE : A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder

enthalten in: Cell reports. Medicine | 2020

von Pierson, S. | Khor, J. | Ziglar, J. | +31

5

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease

enthalten in: Blood advances | 2020

von van Rhee, F. | Oksenhendler, E. | Srkalovic, G. | +26

6

Increased mTOR activation in idiopathic multicentric Castleman disease

enthalten in: Blood | 2020

von Arenas, D. | Floess, K. | Kobrin, D. | +14

CommentIn: Blood. 2020 May 7;135(19):1614-1615. - PMID 32379877

7

Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease

enthalten in: JCI insight | 2020

von Pai, R. | Japp, A. | Gonzalez, M. | +12

8

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

enthalten in: The Journal of clinical investigation | 2019

von Fajgenbaum, D. | Langan, R. | Japp, A. | +20

CommentIn: J Clin Invest. 2019 Oct 1;129(10):4086-4088. - PMID 31524635

9

Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease : secondary analyses of phase II clinical trial data

enthalten in: British journal of haematology | 2019

von Morra, D. | Pierson, S. | Shilling, D. | +6

10

Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease

enthalten in: American journal of hematology | 2018

von Pierson, S. | Stonestrom, A. | Shilling, D. | +8